Order Article Reprints

Smith YE, Wang G, Flynn CL, Madden SF, MacEneaney O, Cruz RGB, Richards CE, Jahns H, Brennan M, Cremona M, et al. Functional Antagonism of Junctional Adhesion Molecule-A (JAM-A), Overexpressed in Breast Ductal Carcinoma In Situ (DCIS), Reduces HER2-Positive Tumor Progression. Cancers. 2022; 14(5):1303. https://doi.org/10.3390/cancers14051303

Smith, Yvonne E., Guannan Wang, Ciara L. Flynn, Stephen F. Madden, Owen MacEneaney, Rodrigo G. B. Cruz, Cathy E. Richards, Hanne Jahns, Marian Brennan, Mattia Cremona, and et al. 2022. "Functional Antagonism of Junctional Adhesion Molecule-A (JAM-A), Overexpressed in Breast Ductal Carcinoma In Situ (DCIS), Reduces HER2-Positive Tumor Progression" Cancers 14, no. 5: 1303. https://doi.org/10.3390/cancers14051303

Smith, Y. E., Wang, G., Flynn, C. L., Madden, S. F., MacEneaney, O., Cruz, R. G. B., Richards, C. E., Jahns, H., Brennan, M., Cremona, M., Hennessy, B. T., Sheehan, K., Casucci, A., Sani, F. A., Hudson, L., Fay, J., Vellanki, S. H., O’Flaherty, S., Devocelle, M., ... Hopkins, A. M. (2022). Functional Antagonism of Junctional Adhesion Molecule-A (JAM-A), Overexpressed in Breast Ductal Carcinoma In Situ (DCIS), Reduces HER2-Positive Tumor Progression. Cancers, 14(5), 1303. https://doi.org/10.3390/cancers14051303